Everence Capital Management’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$235K Hold
5,798
– – 0.01% 723
2026
Q2
$304K Buy
+5,798
New +$226K 0.02% 625
2025
Q2
– Sell
-9,540
Closed -$315K – 789
2025
Q1
$315K Hold
9,540
– – 0.02% 542
2024
Q4
$274K Sell
9,540
-8,840
-48% -$254K 0.02% 621
2024
Q3
$514K Buy
18,380
+5,110
+39% +$136K 0.03% 419
2024
Q2
$326K Hold
13,270
– – 0.02% 520
2024
Q1
$359K Buy
13,270
+4,440
+50% +$126K 0.02% 519
2023
Q4
$245K Buy
+8,830
New +$229K 0.02% 629

Other funds holding ALKS

Everence Capital Management's ALKS Position: Q3 2026 in Review

Everence Capital Management held its Alkermes (ALKS) position steady in Q3 2026 at 5,798 shares worth $235K. The position accounts for 0.01% of the portfolio, ranked #723.

Everence Capital Management first reported a position in ALKS in Q4 2023 and has held it in 8 quarters since. The position peaked at $514K in Q3 2024. 312 funds tracked by Wall St. Rank hold ALKS as of Q3 2026.

  • Everence Capital Management held 5,798 shares of Alkermes worth $235K as of Q3 2026.
  • Everence Capital Management left its Alkermes share count unchanged in Q3 2026.
  • Alkermes made up 0.01% of Everence Capital Management's portfolio in Q3 2026, its #723 holding.
  • Everence Capital Management first reported a position in Alkermes in Q4 2023 and has held it in 8 quarters since.
  • Everence Capital Management's Alkermes position peaked at $514K in Q3 2024.
  • 312 funds tracked by Wall St. Rank held Alkermes as of Q3 2026.

Based on Everence Capital Management's 13F filing for Q3 2026, filed 3 Nov 2026.